Federated Hermes, Inc. Protagonist Therapeutics, Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$16.68 - $23.66 $508,856 - $721,795	30,507 Added 102.62%	60,234 $1 Million
Q2 2023 Aug 14, 2023	BUY	$18.02 - $29.36 $1,333 - $2,172	74 Added 0.25%	29,727 $821,000
Q1 2023 May 08, 2023	SELL	$10.78 - $25.38 $184,930 - $435,393	-17,155 Reduced 36.65%	29,653 $682,000
Q4 2022 Feb 13, 2023	BUY	$7.36 - $11.17 $344,506 - $522,845	46,808 New	46,808 $510,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $25.52 $197 - $714	28 New	28 $1,000
Q4 2021 Feb 14, 2022	SELL	$17.63 - $37.1 $2.31 Million - $4.87 Million	-131,282 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $897,007 - $3.44 Million	69,267 Added 111.69%	131,282 $2.33 Million
Q2 2021 Aug 16, 2021	BUY	$25.57 - $44.88 $1.59 Million - $2.78 Million	62,015 New	62,015 $2.78 Million
Q1 2021 May 13, 2021	SELL	$19.02 - $31.15 $817,707 - $1.34 Million	-42,992 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$18.49 - $25.13 $792,980 - $1.08 Million	42,887 Added 40844.76%	42,992 $867,000
Q3 2020 Nov 12, 2020	BUY	$15.19 - $22.4 $1,594 - $2,352	105 New	105 $2,000
Q3 2019 Nov 14, 2019	SELL	$9.41 - $16.56 $2,860 - $5,034	-304 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.98 - $12.96 $1,167 - $1,684	130 Added 74.71%	304 $4,000
Q1 2019 May 10, 2019	BUY	$6.5 - $13.77 $1,131 - $2,395	174 New	174 $2,000
Q3 2018 Nov 13, 2018	SELL	$6.82 - $11.26 $86,491 - $142,799	-12,682 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$5.99 - $9.1 $306,921 - $466,274	-51,239 Reduced 80.16%	12,682 $85,000
Q1 2018 May 09, 2018	BUY	$8.46 - $23.08 $393,356 - $1.07 Million	46,496 Added 266.84%	63,921 $549,000
Q4 2017 Feb 14, 2018	BUY	$14.47 - $20.8 $252,139 - $362,440	17,425	17,425 $0

Others Institutions Holding PTGX

# of Institutions

247

Shares Held

56.4M

Call Options Held

76.3K

Put Options Held

114K

Farallon Capital Management LLC San Francisco, CA

5.86M
Shares

$238 Million
1.32% of portfolio
Black Rock Inc. New York, NY

5.76M
Shares

$234 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$221 Million
3.89% of portfolio
Vanguard Group Inc Valley Forge, PA

4.22M
Shares

$172 Million
0.0% of portfolio
State Street Corp Boston, MA

3.18M
Shares

$130 Million
0.01% of portfolio

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account